Investors
Occuity's investment round is now CLOSED.
Whilst we are last investment round is closed in December 2024, please do feel free to register your interest in being the first to know about any future opportunities.
We're committed to improving the lives of millions by addressing some of humanity's most prevalent diseases. Continue reading to explore this unique investment opportunity.
Introduction
Occuity is using the eye as a window to a persons health.
Some of the world’s most prevalent diseases such as diabetes, Alzheimer’s Disease and sepsis leave telltale markers in the human eye; other conditions, such as myopia, can be characterised by tiny changes to its physiology – specifically where the axial length of the eye grows too long.
Currently the tests to screen or monitor the progression of these conditions, which affect a huge percentage of the global population, are either invasive, extremely cumbersome, or nonexistent.
Occuity’s mission is to provide the solution to this problem and radically change how these diseases are detected and monitored.
Already capable of highly accurate measurement of structures within the eye, Occuity is further developing its ground-breaking technology to detect, analyse and record the amount and distribution of these disease markers in simple optical scans that take just a few seconds; providing an insight into an individual’s progression along a particular disease pathway whilst simultaneously creating a valuable dataset from the information captured each time a scan is undertaken.
Ultimately Occuity’s aim is to unlock the valuable health data held by the eye and become a world leader in the burgeoning field of Oculomics.
As the volume of the data collected builds up over time it will increasingly form a significant part of Occuity’s long term value creation strategy; both in the enhanced information that can be provided to individual patients and as population data for use by corporates, healthcare agencies and government bodies.